Barnes Group Inc (B) Actualités

Kuehn Law Encourages NXU, B, KIO, and LBRDA Investors to Contact Law Firm

Kuehn Law Encourages NXU, B, KIO, and LBRDA Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 18, 2024...

Form PREM14A - Preliminary proxy statements relating to merger or acquisition

BrainTransporter™ dramatically improves antibody delivery to the brain

BrainTransporter™ dramatically improves antibody delivery to the brain PR Newswire STOCKHOLM, Nov. 6, 2024 STOCKHOLM, Nov. 6, 2024 /PRNewswire/...

BrainTransporter™ dramatically improves antibody delivery to the brain

BrainTransporter™ dramatically improves antibody delivery to the brain PR Newswire STOCKHOLM, Nov. 6, 2024 STOCKHOLM, Nov. 6, 2024 /PRNewswire/...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm

Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm PR Newswire NEW YORK, Nov. 1, 2024...

Form 144 - Report of proposed sale of securities

Largest university hospital in Belgium chooses digital pathology from Sectra to further enhance cancer diagnostics

Largest university hospital in Belgium chooses digital pathology from Sectra to further enhance cancer diagnostics PR Newswire LINKÖPING, Sweden...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Barnes Reports Third Quarter 2024 Financial Results

Strong Aerospace Aftermarket Drives Top-line Growth Comparisons are year-over-year unless noted otherwise Third Quarter 2024: Sales of $388...

Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD

Lifetime Achievement Award, lecanemab and biomarkers in focus at CTAD PR Newswire STOCKHOLM, Oct. 24, 2024 STOCKHOLM, Oct. 24, 2024 /PRNewswire/...